Contracts for Innovation: industrial human relevant drug models
Organisations can apply for a share of £2 million, inclusive of VAT, to develop and commercialise non‑animal methods for assessing the pre‑clinical pharmacokinetics and cardiovascular safety of new medicines.
Eligibility
To lead a project, you can:
- be an organisation of any size, including those based in the EU, EEA or internationally
- work alone or with other organisations as subcontractors
Opening soon
- Opens:
- 2 March 2026
- Closes:
- 15 April 2026
Recommended Comments
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.